V A Shkurupy Selected Research

dextrazide

3/2021	Effect of Liposome-Encapsulated Dextrazide on Local Regulation of Extracellular Matrix Metabolism in Liver and Lungs of Mice with during Chronic BCG-Induced Granulomatosis.
2/2021	Content of the Major Extracellular Matrix Components of the Liver and Lungs in Mice with Chronic BCG-Granulomatosis Treated with Liposome-Encapsulated Dextrazide.
2/2021	Destructive Processes and Fibrotic Complications in the Liver of Mice with BSG-Induced Granulomatosis Treated with Anti-Tuberculous Drugs.
12/2020	Analysis of the Efficiency of Different Antituberculous Drugs and Approaches to Treat BCG-Induced Granulomatosis in Mice and Abundance and Localization of Mycobacterium tuberculosis in the Liver.
5/2020	Location of Pulmonary Mycobacteria Tuberculosis and Effectiveness of Various Dextrazide Compositions in Treatment of Mice with BCG-Induced Granulomatosis.
3/2020	Structural Changes in the Lungs and Liver of Mice with Experimental Tuberculosis Treated with Liposome-Encapsulated Dextrazide.
12/2019	Effect of Liposomal Delivery of Oxidized Dextran with Isonicotinic Acid Hydrazide on Component Profile of Pulmonary Extracellular Matrix in Mice with BCG-Induced Granulomatosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V A Shkurupy Research Topics

Disease

13	Infections 11/2021 - 08/2008
12	Granuloma 02/2021 - 09/2008
6	Tuberculosis (Tuberculoses) 05/2020 - 01/2015
5	Fibrosis (Cirrhosis) 01/2023 - 02/2016
4	Inflammation (Inflammations) 02/2016 - 04/2007
3	Human Influenza (Influenza) 05/2018 - 11/2014
2	Body Weight (Weight, Body) 03/2020 - 05/2016
1	Necrosis 01/2023
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023
1	Hydrothorax 01/2023
1	Ascites 01/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2019
1	Burns 03/2015
1	Cicatrix (Scar) 03/2015
1	Wounds and Injuries (Trauma) 03/2015
1	Systemic candidiasis 04/2007

Drug/Important Bio-Agent (IBA)

8	Dextrans (Dextran)FDA Link 01/2023 - 11/2014
7	BCG Vaccine FDA Link 11/2021 - 08/2008
7	dextrazideIBA 03/2021 - 12/2019
6	CollagenIBA 01/2023 - 01/2013
5	Liposomes (Liposome)IBA 02/2021 - 03/2020
4	Proteoglycans (Proteoglycan)IBA 07/2018 - 01/2015
4	CytokinesIBA 05/2018 - 02/2013
3	Isoniazid (Ftivazide)FDA LinkGeneric 03/2021 - 12/2020
3	GlycosaminoglycansIBA 02/2021 - 01/2015
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 09/2013 - 07/2012
2	Matrix Metalloproteinases (MMPs)IBA 03/2021 - 12/2019
2	Hyaluronic Acid (Hyaluronan)IBA 02/2021 - 02/2016
2	Hydroxyproline (4 Hydroxyproline)IBA 02/2021 - 12/2019
2	PlasticsIBA 08/2020 - 02/2015
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	SolutionsIBA 01/2023
1	Peptide Hydrolases (Proteases)FDA Link 03/2021
1	Protease Inhibitors (Protease Inhibitor)IBA 03/2021
1	Interleukin-6 (Interleukin 6)IBA 02/2021
1	A-factor (Streptomyces)IBA 08/2020
1	SuspensionsIBA 03/2020
1	Tissue Inhibitor of Metalloproteinase-2IBA 12/2019
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2019
1	Antitubercular AgentsIBA 09/2019
1	Transcription Factors (Transcription Factor)IBA 04/2018
1	LigandsIBA 05/2016
1	S(8)IBA 05/2016
1	dexpanthenol (panthenol)FDA Link 03/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	VaccinesIBA 01/2015
1	HydrolasesIBA 02/2013
1	AntigensIBA 01/2013
1	Chemotactic FactorsIBA 07/2012
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2010
1	RadonIBA 09/2008
1	Therapeutic UsesIBA 04/2007
1	Amphotericin B (Amphotericin)FDA LinkGeneric 04/2007
1	dextran dialdehydeIBA 04/2007
1	GlucocorticoidsIBA 04/2007

Therapy/Procedure

2	Intraperitoneal Injections 01/2023 - 12/2020
2	Injections 05/2018 - 02/2015
2	Intravenous Injections 05/2016 - 11/2014
1	Therapeutics 05/2020
1	Drug Administration Routes 05/2020
1	Baths 09/2008